EUVIMEDEUVIMED entdecken
Crossref

Artematrolide F suppresses communication between hepatocellular carcinoma cells and hepatic stellate cells to attenuate liver cancer progression through targeting YKT6

Qi-Hao Li, Tian-Ze Li, Yong-Cui Wang, Yao Yang, Ji-Jun Chen

Cellular Signalling · 2026-09 · 145 · 112618

DOI: 10.1016/j.cellsig.2026.112618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026-09. Verfasst von Qi-Hao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Yunnan University, Kunming 650500, China; Kunming Institute of Botany, Chinese Academy of Sciences, State Key Laboratory of …. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Liver Neoplasms, Carcinoma, Hepatocellular, Cell Communication. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Kunming Institute of Botany, Chinese Academy of Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains a highly malignant cancer with limited treatment options. HCC cells (HCCs) activate hepatic stellate cells (HSCs) and transform them into cancer-associated fibroblasts (CAFs), forming a vicious cycle for hepatocarcinogenesis. Therefore, inhibition of the communication between HCCs and HSCs is expected to emerge as a novel strategy for HCC treatment. Artematrolide F (AF), a sesquiterpenoid dimers (SDs) isolated from Artemisia atrovirens, exhibited significantly inhibitory activity on tumor cells in our previous report, but its mechanism remains unknown. This further study demonstrated that AF significantly inhibited the proliferation, colony formation and metastasis of HCCs. Notably, the inhibitory effect was enhanced when HCCs were cocultured with HSCs, suggesting that AF may suppress tumor progression through regulating the crosstalk of HCCs and HSCs. The vesicular transport protein YKT6 was identified as a target of AF through integrating bioinformatics analysis and machine learning model, which were verified by DARTS, CETSA, molecular docking, molecular dynamics simulation, and knockdown experiments. Further mechanistic research revealed that AF targeting YKT6 disrupted the crosstalk between HSCs and HCCs, suppressed HSC-driven tumor proliferation by inhibiting extracellular vesicles (EVs) secretion from HCCs, and blocked tumor autophagy by disrupting vesicular transport. These findings demonstrate that AF could serve as a novel therapeutic candidate for HCC treatment through regulating YKT6 to suppress HCCs-HSCs communication, block EV-dependent tumor progression, and inhibit tumor autophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsLiver NeoplasmsCarcinoma, HepatocellularCell CommunicationSesquiterpenesHumansAnimalsCell Line, TumorCell ProliferationDisease ProgressionCell Movement

Stichwörter der Autor:innen

Artematrolide FAutophagyExtracellular vesiclesHCCs–HSCs crosstalkHepatocellular carcinomaYKT6

Substanzen

Sesquiterpenes

Autor:innen und Institutionen

  • School of Life Sciences, Yunnan University, Kunming 650500, China; Kunming Institute of Botany, Chinese Academy of Sciences, State Key Laboratory of Phytochemistry and Natural Medicines, Kunming 650201, China; Universit…
  • Kunming Institute of Botany, Chinese Academy of Sciences, State Key Laboratory of Phytochemistry and Natural Medicines, Kunming 650201, China.
  • Kunming Institute of Botany, Chinese Academy of Sciences, State Key Laboratory of Phytochemistry and Natural Medicines, Kunming 650201, China; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Kunming Institute of Botany, Chinese Academy of Sciences, State Key Laboratory of Phytochemistry and Natural Medicines, Kunming 650201, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic…

Förderung

  • Kunming Institute of Botany, Chinese Academy of Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Li, Q. H., Li, T. Z., Wang, Y. C., Yang, Y., & Chen, J. J. (2026). Artematrolide F suppresses communication between hepatocellular carcinoma cells and hepatic stellate cells to attenuate liver cancer progression through targeting YKT6. Cellular Signalling, 145, 112618. https://doi.org/10.1016/j.cellsig.2026.112618

Vancouver

Li QH, Li TZ, Wang YC, Yang Y, Chen JJ. Artematrolide F suppresses communication between hepatocellular carcinoma cells and hepatic stellate cells to attenuate liver cancer progression through targeting YKT6. Cellular Signalling. 2026;145:112618. doi:10.1016/j.cellsig.2026.112618

BibTeX
@article{Li2026,
  author = {Li, Qi-Hao and Li, Tian-Ze and Wang, Yong-Cui and Yang, Yao and Chen, Ji-Jun},
  title = {Artematrolide F suppresses communication between hepatocellular carcinoma cells and hepatic stellate cells to attenuate liver cancer progression through targeting YKT6},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {145},
  pages = {112618},
  doi = {10.1016/j.cellsig.2026.112618}
}
Kostenlos starten →